Janux Therapeutics
#3848
Rank
$2.6B
Marketcap
United States
Country
Dr. David Alan Campbell Ph.D. (Pres, CEO & Director)
Dr. Wayne Godfrey M.D. (Chief Medical Officer)
Mr. Tighe M. Reardon C.F.A., CPA, CPA (Acting Chief Financial Officer)
Summary
History
Janux Therapeutics was founded in 2019 with the goal of revolutionizing the treatment of cancer and other diseases. We are focused on discovering, developing and commercializing novel therapies for the most challenging malignant and infectious diseases. We strive to create treatments that have a meaningful impact on patient outcomes and quality of life.
Mission
Vision
Key Team
Mr. Tommy Diraimondo Ph.D. (Sr. Director of Research)
Ms. Brenda Van Vreeswyk (Head of HR)
Mr. Andy Hollman Meyer (Chief Bus. Officer)
Mr. Byron Robinson J.D., Ph.D. (Chief Strategy Officer)
Mr. Charles M. Winter (Sr. VP of Chemistry, Manufacturing & Controls)
Recognition and Awards
References
Dr. David Alan Campbell Ph.D. (Pres, CEO & Director)
Dr. Wayne Godfrey M.D. (Chief Medical Officer)
Mr. Tighe M. Reardon C.F.A., CPA, CPA (Acting Chief Financial Officer)